The DOI matches its Crossref record; 94 of the 98 references it cites were found in a registry or an index.
Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis
Abstract
OBJECTIVE: We aimed to estimate pooled percentages of patients with adrenal insufficiency after treatment with corticosteroids for various conditions in a meta-analysis. Secondly, we aimed to stratify the results by route of administration, disease, treatment dose, and duration. METHODS: We searched seven electronic databases (PubMed, MEDLINE, EMBASE, COCHRANE, CENTRAL, Web of Science, and CINAHL/Academic Search Premier) in February 2014 to identify potentially relevant studies. Original articles testing adult corticosteroid users for adrenal insufficiency were eligible. RESULTS: We included 74 articles with a total of 3753 participants. Stratified by administration form, percentages of patients with adrenal insufficiency ranged from 4.2% for nasal administration (95% confidence interval [CI], 0.5-28.9) to 52.2% for intra-articular administration (95% CI, 40.5-63.6). Stratified by disease, percentages ranged from 6.8% for asthma with inhalation corticosteroids only (95% CI, 3.8-12.0) to 60.0% for hematological malignancies (95% CI, 38.0-78.6). The risk also varied according to dose from 2.4% (95% CI, 0.6-9.3) (low dose) to 21.5% (95% CI, 12.0-35.5) (high dose), and according to treatment duration from 1.4% (95% CI, 0.3-7.4) (<28 d) to 27.4% (95% CI, 17.7-39.8) (>1 year) in asthma patients. CONCLUSIONS: 1) Adrenal insufficiency after discontinuation of glucocorticoid occurs frequently; 2) there is no administration form, dosing, treatment duration, or underlying disease for which adrenal insufficiency can be excluded with certainty, although higher dose and longer use give the highest risk; 3) the threshold to test corticosteroid users for adrenal insufficiency should be low in clinical practice, especially for those patients with nonspecific symptoms after cessation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risk also varied when stratified for the underlying disease and increased with higher dose (low dose 2.4% (95% CI 0.6-9.3) to high dose 21.5% (95% CI 12.0-35.5)) and longer treatment duration (1.4% (95% CI 0.3-7.4) (<28 days) to 27.4% (95% CI 17.7-39.8) (>1 year)) in patients with asthma.”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“A meta-analysis of the risk of developing biochemical glucocorticoid-induced adrenal insufficiency stratified by glucocorticoid route of administration showed pooled percentages of 4.2% (95% CI 0.5-28.9) for nasal administration, 48.7% (95% CI 36.9-60.6) for oral use, and 52.2% (95% CI 40.5-63.6) for intra-articular administration (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“Of these 521 patients, 98 patients had biochemical evidence of adrenal insufficiency. Ten of them (10%) reported symptoms. However, 88 (90%) did not report any symptoms”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“In the above-mentioned meta-analysis, ten of the 74 included studies also assessed symptoms of adrenal insufficiency (although not systematically scored) in a total of 521 patients (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“Broersen et al performed a meta-analysis on eleven out of seventeen studies re-testing patients for biochemical adrenal insufficiency for which results could be categorized in short-term (defined as less than 4 weeks) high-dose glucocorticoid therapy re-testing after 4 weeks (six studies), and long-term (>1 year) medium-dose glucocorticoid therapy re-testing after 6 months (five studies) (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
20 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
Oelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442
Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260403 · Cited by 381
Distinguishing Case Series From Cohort Studies
Dekkers, O. M., Egger, M., Altman, D. G., & Vandenbroucke, J. P. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-1-201201030-00006 · Cited by 308
Self-citationSuppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment
Henzen, C., Suter, A., Lerch, E., Urbinelli, R., Schorno, X. H., & Briner, V. A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06290-x · Cited by 290
Greenberg, G., Feagan, B., Martin, F., Sutherland, L., Thomson, A., Williams, C., Nilsson, L., & Persson, T. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536887 · Cited by 288
Systemic effects of intra-articular corticosteroids
Habib, G. S. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1135-x · Cited by 273
Broide, J. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1243 · Cited by 269
Glucocorticoid-induced adrenal insufficiency
Krasner, A. S. (1999) · JAMA · doi:10.1001/jama.282.7.671 · Cited by 197
Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids
Hanania, N. A., Chapman, K. R., Sturtridge, W. C., Szalai, J. P., & Kesten, S. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70254-7 · Cited by 173
Plumpton, F. S., & Besser, G. M. (1969) · Journal of British Surgery · doi:10.1002/bjs.1800560315 · Cited by 170
LaRochelle, G. E., LaRochelle, A. G., Ratner, R. E., & Borenstein, D. G. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90277-v · Cited by 165
Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function.
Smith, M. J., & Hodson, M. E. (1983) · Thorax · doi:10.1136/thx.38.9.676 · Cited by 151
Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself
Dinsen, S., Baslund, B., Klose, M., Rasmussen, A. K., Friis-Hansen, L., Hilsted, L., & Feldt-Rasmussen, U. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.05.014 · Cited by 148
Skov, M., Main, K. M., Ib, S., Müller, J., Koch, C., & Lanng, S. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00248002 · Cited by 142
Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy
Franz, T., Parsell, D. A., Halualani, R., Hannigan, J. F., Kalbach, J. P., Ma, & Harkonen, W. S. (1999) · International Journal of Dermatology · doi:10.1046/j.1365-4362.1999.00782.x · Cited by 121
ADRENAL SUPPRESSION AND STEROID SUPPLEMENTATION IN RENAL TRANSPLANT RECIPIENTS
Bromberg, J. S., Alfrey, E. J., Barker, C. F., Chavin, K. D., Dafoe, D. C., HOLLAND, T., Naji, A., Perloff, L. J., Zellers, L., & GROSSMAN, R. A. (1991) · Transplantation · doi:10.1097/00007890-199102000-00023 · Cited by 115
Observations on the systemic effect of topical clobetasol propionate (Dermovate).
Carruthers, J. A., August, P. J., & Staughton, R. C. D. (1975) · BMJ · doi:10.1136/bmj.4.5990.203 · Cited by 112
Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids?
Brown, P. H., Blundell, G., Greening, A. P., & Crompton, G. K. (1990) · Thorax · doi:10.1136/thx.45.10.736 · Cited by 110
ADRENAL SUPPRESSION AFTER SHORT-TERM CORTICOSTEROID THERAPY
Rj, S., Oliff, A., Bruton, J., Vigersky, R., Echelberger, C. K., & Poplack, D. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91077-8 · Cited by 107
Wilson, A. M., McFarlane, L. C., & Lipworth, B. J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70354-9 · Cited by 103
A simple radioimmunoassay for plasma cortisol
Seth, J., & Brown, L. M. (1978) · Clinica Chimica Acta · doi:10.1016/0009-8981(78)90465-5 · Cited by 98
Affrime, M. B., Kosoglou, T., Thonoor, C. M., Flannery, B. E., & Herron, J. M. (2000) · CHEST Journal · doi:10.1378/chest.118.6.1538 · Cited by 87
Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids
Brown, P. H., Blundell, G., Greening, A. P., & Crompton, G. K. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80268-4 · Cited by 84
Gonzálbez, Villabona, Ramón, Navarro, Giménez, Ricart, & Soler (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01028.x · Cited by 82
Effect on adrenal function of topically applied clobetasol propionate (Dermovate).
Allenby, C. F., Main, R. A., Marsden, R. A., & Sparkes, C. G. (1975) · BMJ · doi:10.1136/bmj.4.5997.619 · Cited by 76
Nelson, H. S., Busse, W. W., deBoisblanc, B. P., Berger, W. E., Noonan, M. J., Webb, D. R., Wolford, J. P., Mahajan, P. S., Hamedani, A. G., Shah, T. P., et al. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70501-4 · Cited by 72
Vargas, R., Dockhorn, R. J., Findlay, S. R., Korenblat, P. E., Field, E. A., & Kral, K. M. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70085-5 · Cited by 67
A 12-Week Dose-Ranging Study of Fluticasone Propionate Powder in the Treatment of Asthma
Wasserman, S. I., Gross, G. N., Schoenwetter, W. F., Munk, Z. M., Kral, K. M., Schaberg, A. E., & Kellerman, D. J. (1996) · Journal of Asthma · doi:10.3109/02770909609055367 · Cited by 67
Aaronson, D., Kaiser, H. B., Dockhorn, R. J., Findlay, S. R., Korenblat, P., Thorsson, L., & Källén, A. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70241-6 · Cited by 62
Jamilloux, Y., Liozon, E., Pugnet, G., Nadalon, S., Heang Ly, K., Dumonteil, S., Gondran, G., Fauchais, A.-L., & Vidal, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068713 · Cited by 59
High Risk of Adrenal Insufficiency after a Single Articular Steroid Injection in Athletes
Duclos, M., Guinot, M., Colsy, M., Merle, F., Baudot, C., Corcuff, J. B., & Bouc, Y. L. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31805468d6 · Cited by 58
Brown, P. H., Greening, A. P., & Crompton, G. K. (1993) · Thorax · doi:10.1136/thx.48.3.233 · Cited by 57
Adrenal suppression and osteoporosis after treatment of nasal polyposis
Bonfils, P., Halimi, P., & Malinvaud, D. (2006) · Acta Oto-Laryngologica · doi:10.1080/00016480600672667 · Cited by 54
Habib, G., Jabbour, A., Artul, S., & Hakim, G. (2014) · Clinical Rheumatology · doi:10.1007/s10067-013-2374-4 · Cited by 52
Sacre, K., Dehoux, M., Chauveheid, M. P., Chauchard, M., Lidove, O., Roussel, R., & Papo, T. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1394 · Cited by 52
Kane, K. F., Emery, P., Sheppard, M. C., & Stewart, P. (1995) · QJM · doi:10.1093/oxfordjournals.qjmed.a069058 · Cited by 52
Masoli, M., Weatherall, M., Holt, S., Shirtcliffe, P., & Beasley, R. W. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00119305 · Cited by 51
Hypothalamic-Pituitary-Adrenal Axis Suppression and Inhaled Corticosteroid Therapy
Chrousos, G. P., & Harris, A. G. (1998) · Neuroimmunomodulation · doi:10.1159/000026348 · Cited by 50
An immunoassay for plasma cortisol based on chemiluminescence
Kohen, F., Pazzagli, M., Kim, J. B., & Lindner, H. R. (1980) · Steroids · doi:10.1016/0039-128x(80)90030-6 · Cited by 49
Shapiro, R., Carroll, P. B., Tzakis, A. G., Cemaj, S., Lopatin, W. B., & Nakazato, P. Z. (1990) · Transplantation · doi:10.1097/00007890-199005000-00039 · Cited by 48
Kirwan, J., Hickey, S., Hällgren, R., Mielants, H., Björck, E., Persson, T., & Wollheim, F. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21747 · Cited by 47
Thamboo, A. V., Manji, J., Szeitz, A. J., Santos, R. D., Hathorn, I. F., Gan, E. C., Alsaleh, S. A., & Javer, A. R. (2014) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21280 · Cited by 43
Topical Corticosteroid Therapy and Pituitary-Adrenal Function
Krupin, T., Mandell, A. I., Podos, S. M., & Becker, B. (1976) · Archives of Ophthalmology · doi:10.1001/archopht.1976.03910030459003 · Cited by 42
Hypothalamic-pituitary-adrenal function one week after a short burst of steroid therapy
Carella, M. J., Srivastava, L., Gossain, V. V., & Rovner, D. R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.5.8388401 · Cited by 42
Adrenal suppression in bronchiectasis and the impact of inhaled corticosteroids
Holme, J., Tomlinson, J., Stockley, R. A., Stewart, P. M., Barlow, N. L., & Sullivan, A. (2008) · European Respiratory Journal · doi:10.1183/09031936.00016908 · Cited by 39
Sorkness, C. A., LaForce, C., Storms, W. W., Lincourt, W. R., Edwards, L. D., & Rogenes, P. R. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88292-2 · Cited by 37
Li, J. T. C., Goldstein, M. F., Gross, G. N., Noonan, M. J., Weisberg, S., Edwards, L. D., Reed, K. D., & Rogenes, P. R. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70234-4 · Cited by 37
Gilchrist, F. J., Cox, K. J., Rowe, R., Horsley, A. R., Webb, A. K., Jones, A. M., & Bright-Thomas, R. J. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.10.007 · Cited by 36
Svendsen, U. G., FRØLUND, L., Heinig, J. H., Madsen, F., Nielsen, N. H., & Weeke, B. (1992) · Allergy · doi:10.1111/j.1398-9995.1992.tb00960.x · Cited by 35
Schlessinger, J., Miller, B. H., Gilbert, R. D., & Plott, R. T. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.12.1568 · Cited by 35
Gazis, A. G., Homer, J. J., Henson, D. B., Page, S. R., & Jones, N. S. (1999) · Clinical Otolaryngology and Allied Sciences · doi:10.1046/j.1365-2273.1999.00299.x · Cited by 32
Andrès, P., Poncet, M., Sidou, F., & Soto, P. (2006) · PubMed · Cited by 31
Clark, D. J., & Lipworth, B. J. (1997) · CHEST Journal · doi:10.1378/chest.112.5.1248 · Cited by 30
Rodger, R. S. C., Watson, M. J., Sellars, L., Wilkinson, R., Ward, M. K., & Kerr, D. N. S. (1986) · QJM · doi:10.1093/oxfordjournals.qjmed.a068059 · Cited by 29
Ficher, M., Curtis, G. C., Ganjam, V. K., Joshlin, L., & Perry, S. (1973) · Clinical Chemistry · doi:10.1093/clinchem/19.5.511 · Cited by 26
Lee, D. K. C., Bates, C. E., Currie, G. P., Cowan, L. M., McFarlane, L. C., & Lipworth, B. J. (2004) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61497-4 · Cited by 26
Wilson, A. M., Sims, E. J., & Lipworth, B. J. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00652.x · Cited by 26
Carr, P. J., Millar, R. P., & Crowley, H. (1977) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456327701400157 · Cited by 25
Grebe, S. K. G., Feek, C. M., Durham, J. A., Kljakovic, M., & Cooke, R. R. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2391059.x · Cited by 24
Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation
Boots, J. M. M., van den Ham, E. C. H., Christiaans, M. H. L., & van Hooff, J. P. (2002) · Transplantation Proceedings · doi:10.1016/s0041-1345(02)02987-1 · Cited by 24
Habib, G. S., Artul, S., Chernin, M., Hakim, G., & Jabbour, A. R. (2013) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3182a67871 · Cited by 24
Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma
White, M., Crisalida, T., Li, H., Economides, A., & Kaliner, M. (2006) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60911-8 · Cited by 23
Habib, G., Khazin, F., Jabbour, A., Chernin, M., Badarny, S., Hakim, J., & Artul, S. (2014) · Journal of Investigative Medicine · doi:10.2310/jim.0000000000000048 · Cited by 21
A pilot study of adrenal suppression after dexamethasone therapy as an antiemetic in cancer patients
Han, H., Shim, Y. K., Kim, J. E., Jeon, H., Lim, S.-N., Oh, T., Lee, K. H., & Kim, S. T. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1248-z · Cited by 21
Fleming, C., Ganslandt, C., & Leese, G. (2010) · PubMed · Cited by 20
González‐Moles, M. Á., & Scully, C. M. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03591.x · Cited by 20
The effect of a steroid “burst” and long-term, inhaled fluticasone propionate on adrenal reserve
Nguyen, K.-L., Lauver, D., Kim, I., & Aresery, M. (2003) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62056-x · Cited by 20
Patel, R. S., Wallace, E. M., Hinnie, J., & McGarry, G. W. (2001) · Clinical Otolaryngology · doi:10.1046/j.0307-7772.2001.00462.x · Cited by 19
Silver, S., Tuppal, R., Gupta, A. K., Clonier, F., Olesen, M., Leeder, R., & Taraska (2013) · PubMed · Cited by 16
Efficacy and systemic tolerability of mometasone furoate and betamethasone sodium phosphate
Patel, R. S., Shaw, S. R., Wallace, A. M., & McGarry, G. W. (2004) · The Journal of Laryngology & Otology · doi:10.1258/0022215042703769 · Cited by 16
CRH test prior to discontinuation of long-term low-dose glucocorticoid therapy
Gellner, R., Stange, M., Schiemann, U., Domschke, W., & Hengst, K. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1232566 · Cited by 14
Canafax, D. M., Mann, H. J., Sutherland, D. E. R., Simmons, R. L., & Najarian, J. S. (1983) · Transplantation · doi:10.1097/00007890-198308000-00006 · Cited by 14
Wilson, K. S., Gray, C., CAMERON, E. H. D., Seth, J., & Parker, A. C. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90417-7 · Cited by 13
Baz‐Hecht, M., Osher, E., Yachnin, T., Nakache, R., Nakache, G., Tordjman, K., & Stern, N. (2006) · Clinical Transplantation · doi:10.1111/j.1399-0012.2005.00443.x · Cited by 13
Neidert, S., Schuetz, P., Mueller, B., & Christ-Crain, M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0930 · Cited by 13
Niitsuma, T., Okita, M., Sakurai, K., Morita, S., Tsuyuguchi, M., Matsumura, Y., Hayashi, T., Koshishi, T., Oka, K., & Homma, M. (2003) · Journal of Asthma · doi:10.1081/jas-120018781 · Cited by 12
Mass spectrometry for steroid assays
Dufour‐Rainfray, D., Moal, V., Cloix, L., Mathieu, E., Gauchez, A., Brossaud, J., Corcuff, J., Fraissinet, F., Collet, C., de Casson, F. B., et al. (2015) · Annales de biologie clinique · doi:10.1684/abc.2014.0988 · Cited by 11
Sandhu, S. S., Smith, J. M., Doherty, M., James, A., & Figueiredo, F. C. (2012) · Eye · doi:10.1038/eye.2012.12 · Cited by 10
Nelson, H. S., Kane, R. E., Petillo, J., & Banerji, D. D. (2000) · Journal of Asthma · doi:10.3109/02770900009055437 · Cited by 10
HPA Failure and Glucocorticoid Therapy
Christy, N. P. (1984) · Hospital Practice · doi:10.1080/21548331.1984.11702864 · Cited by 10
Visscher, H. W., Ebels, J. T., Jonkman, J., & RODERS, G. (1995) · European Journal of Clinical Pharmacology · doi:10.1007/bf00192736 · Cited by 8
Bondarevsky, E. (1976) · JAMA · doi:10.1001/jama.236.17.1969 · Cited by 6
Kos‐Kudła, B. (1998) · PubMed · Cited by 5
Hasegawa, T., Ishihara, K., Fujii, H., Hajiro, T., WATANABE, I., Nishimura, T., Okazaki, M., Katakami, N., & Umeda, B. (1996) · Internal Medicine · doi:10.2169/internalmedicine.35.362 · Cited by 4
Kos‐Kudła, B., Ciesielska-Kopacz, N., Ostrowska, Z., Marek, B., Kajdaniuk, D., Staszewicz, P., & Fołtyn, W. (2003) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2003.00466.x · Cited by 4
The effect of inhaled corticosteroids on hypothalamic-pituitary-adrenal axis
Moghaddam, K. G., Rashidi, N., Meybodi, H. R. A., Rezaie, N., Montazeri, M., Heshmat, R., & Annabestani, Z. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.96300 · Cited by 4
Gupta, D., Behera, D., Lalrinmawia, H., & Rj, D. (2000) · PubMed · Cited by 4
Kasayama, S., Otsuki, M., Tanemura, M., Fujita, K., & Miyatake, A. (2013) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2013.07.001 · Cited by 2
Hirano, T., Shimodaira, H., Oka, K., SAKURAI, E., Kozaki, K., Tamaki, T., & Kozaki, M. (1993) · PubMed · Cited by 2
Research works printed but not linked: 1
- Ruiz Munoz, 1988, Adrenocortical function and steroid doses in renal transplant patients, Dial Transplant, 17, 184
Cited by
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30024-3 · Cited by 1,370
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,228
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 606
Rhinitis 2020: A practice parameter update
Dykewicz, M. S., Wallace, D. V., Amrol, D. J., Baroody, F. M., Bernstein, J. A., Craig, T. J., Dinakar, C., Ellis, A. K., Finegold, I., Golden, D. B. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.007 · Cited by 436
Endocrine toxicities of immune checkpoint inhibitors
Wright, J. J., Powers, A. C., & Johnson, D. B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00484-3 · Cited by 441
Metadata
- Authors
- Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M.
- Affiliations
- Leiden University Medical Center (NL)
- Aarhus University (DK)
- Corresponding author
- Dekkers, Olaf M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-06-01
- Volume
- 100
- Issue
- 6
- Pages
- 2171-2180
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2022140603
- Cited by
- 456
- References
- 98
- Citations by year
- 2026: 39 · 2025: 53 · 2024: 50 · 2023: 55 · 2022: 52 · 2021: 48 · 2020: 53 · 2019: 39 · 2018: 28 · 2017: 20 · 2016: 14 · 2015: 5
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- Novo Nordisk Fonden (NNF-13OC0007869)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- adrenal insufficiency, glucocorticoid-induced adrenal insufficiency, corticosteroid use, glucocorticoid dose, treatment duration, route of administration, intra-articular corticosteroids, inhaled corticosteroids, asthma, hematologic malignancies, adrenal function testing
- MeSH terms
- Adrenal Cortex Hormones, Adrenal Insufficiency, Adult, Dosage Forms, Dose-Response Relationship, Drug, Drug Administration Routes, Drug Administration Schedule, Humans, Inflammation, Neoplasms, Skin Diseases, Organ Transplantation, Transplantation Conditioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.